Table 2.
Methodological characteristics of eligible studies and quality score.
References | Representativeness of population | Sample size | Non-respondents | Ascertainment of the exposure (risk factor) | Comparability | Assessment of the outcome | Statistical test | Total stars |
---|---|---|---|---|---|---|---|---|
Bagley et al. (7) | * | * | * | ** | * | * | * | 8 |
Park et al. (31) | * | * | * | ** | * | * | * | 8 |
Kataoka et al. (32) | * | * | * | ** | * | * | * | 8 |
Rogado et al. (33) | * | — | * | ** | * | * | * | 7 |
Patil et al. (34) | * | * | * | ** | * | * | * | 8 |
Diem et al. (35) | * | — | * | ** | * | * | * | 7 |
Shiroyama et al. (36) | * | * | * | ** | * | * | * | 8 |
Zer et al. (37) | * | — | * | ** | * | * | * | 7 |
Mezquita et al. (38) | * | * | * | ** | * | * | * | 8 |
Fukui et al. (39) | * | — | * | ** | * | * | * | 7 |
Maymani et al. (40) | * | — | * | ** | * | * | * | 7 |
Petrova et al. (41) | * | * | * | ** | * | * | * | 8 |
Liu et al. (42) | * | — | * | ** | * | * | * | 7 |
Möller et al. (43) | * | — | * | ** | * | * | * | 7 |
Hasegawa et al. (44) | * | — | * | ** | * | * | * | 7 |
Dusselier et al. (45) | * | — | * | ** | * | * | * | 7 |
Russo et al. (46) | * | * | * | ** | * | * | * | 8 |
One “*” means one point.